Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05206734
Other study ID # P043
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 5, 2022
Est. completion date August 15, 2023

Study information

Verified date August 2023
Source Momentum Data
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a large population-based analysis in the United Kingdom (UK) using routine primary care data to investigate the risk of mental health conditions in children, adolescents and young adults with Inflammatory Bowel Disease, compared to those without Inflammatory Bowel Disease. The study will also compare the impacts on quality-of-life outcomes and use of healthcare services between people with Inflammatory Bowel Disease with and without mental health conditions.


Description:

This study will use routinely electronic medical record (EMR) data from primary care practices within the Optimum Patient Care Research Database (OPCRD). Stream 1 primary objective is to compare the prevalence and cumulative incidence of mental health conditions in children, adolescents and young adults with a diagnosis of Inflammatory Bowel Disease, compared to matched population controls without a diagnosis of Inflammatory Bowel Disease. The secondary objective is to determine the severity of mental health outcomes in those with and without a diagnosis of Inflammatory Bowel Disease. Stream 2 primary objective is to determine the impact of mental health conditions in children, adolescents and young adults with Inflammatory Bowel Disease on quality-of-life indicators, such as records for absence from work or school, unemployment, sleep disturbance and substance abuse. The secondary objectives are to compare indicators of Inflammatory Bowel Disease severity, such as medication use, surgical intervention, nutritional supplement prescriptions and markers of nutritional status including underweight or growth retardation in children and adolescents, between those with and without mental health conditions. Then to compare healthcare resource utilisation in children, adolescents and young adults with Inflammatory Bowel Disease with and without mental health conditions.


Recruitment information / eligibility

Status Completed
Enrollment 19469
Est. completion date August 15, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 25 Years
Eligibility Inclusion Criteria: - Aged between 5 years and 25 years - Registration with a general practices (GP) contributing routinely collected electronic healthcare data to the Optimum Patient Care Research Database (OPCRD) for more than 6 months during the follow up period - A recorded diagnosis of IBD in the clinical record (cases) Exclusion Criteria: • None

Study Design


Related Conditions & MeSH terms

  • Acute Stress Disorder
  • Adjustment Disorders
  • Anxiety Disorder
  • Anxiety Disorders
  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder
  • Behavioral Disorder
  • Bipolar Disorder
  • Body Dysmorphic Disorders
  • Body Image Disorder
  • Depressive Disorder
  • Depressive Episode
  • Eating Disorders
  • Feeding and Eating Disorders
  • Inflammatory Bowel Diseases
  • Intestinal Diseases
  • Mental Disorders
  • Parasuicide
  • Post-traumatic Stress Disorder
  • Psychological Disorder
  • Recurrent Depressive Disorder
  • Schizophrenia
  • Self Harm
  • Sleep Disturbance
  • Stress Disorders, Post-Traumatic
  • Stress Disorders, Traumatic
  • Stress Disorders, Traumatic, Acute
  • Suicide
  • Suicide, Attempted

Intervention

Other:
Exposure of mental health condition
Primary: Composite of all chronic psychological conditions (depression, anxiety, eating disorders, body image disorders, attention-deficit disorder, behavioural disorders, adjustment disorder, acute stress disorder, and post-traumatic stress disorder). Major recurrent depression or treated depressive episode. Non-phobia related anxiety episode or disorder. Secondary: Self-harm, suicide attempt or suicide related codes, other chronic psychiatric conditions (eating disorders, body image disorders, attention-deficit disorder, behavioural disorders, adjustment disorders, acute stress disorder, schizophrenia, bipolar disorder and post-traumatic stress disorder. Problems with sleep.

Locations

Country Name City State
United Kingdom Momentum Data Ltd London

Sponsors (2)

Lead Sponsor Collaborator
Momentum Data Optimum Patient Care

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stream 1 - Primary Outcome: Prevalence and cumulative incidence of mental health conditions in children, adolescents and young adults with IBD Using routinely collected information from patient electronic medical record (EMR) data, we will investigate the prevalence and cumulative incidence of each mental health condition in cases with a diagnosis of IBD and controls without a diagnosis of IBD. Prevalence and cumulative incidence will be stratified by IBD type (Ulcerative Colitis, Crohn's Disease or IBD Unclassified). IBD classification status and mental health conditions will be identified on the basis diagnosis codes within their EMR. Date of Inflammatory Bowel Disease diagnosis for cases or for controls date of diagnosis for their matched counterpart. End of follow-up will be the first of; point of data extraction, patients 25th birthday or loss to follow-up.
Primary Stream 2 - Primary Outcome: Impact of mental health conditions in children, adolescents and young adults with IBD Determine the association between mental health conditions in children, adolescents and young adults with Inflammatory Bowel Disease on quality-of-life indicators. These indicators will be gathered from the routinely collected EMR data, such as records for absence from work or school, unemployment, sleep disturbance and substance abuse. Index date of 01/01/2015 with 5 years of follow-up.
Secondary Stream 1 - Secondary outcome: Sequelae of mental health conditions in children, adolescents and young adults with IBD Determine the sequelae of mental health conditions in people with and without Inflammatory Bowel Disease. Mental health disease information will be gathered from routinely collected EMR data using diagnosis codes for a range of mental health conditions, comprising of three core phenotypes: anxiety/panic disorders, major depressive disorders or depressive episodes, and other psychological conditions. Mental health condition sequelae will include any coded episode of self-harm or suicide, the development of additional chronic mental health conditions, and recorded sleep disturbance. Date of Inflammatory Bowel Disease diagnosis for cases or for controls date of diagnosis for their matched counterpart. End of follow-up will be the first of; point of data extraction, patients 25th birthday or loss to follow-up.
Secondary Stream 2 - Secondary outcome - IBD severity markers Compare indicators of IBD severity in children, adolescents and young adults with and without mental health conditions. Indicators for disease severity will be gathered from the routinely collected EMR data, including records for medication use, surgical intervention, nutritional supplement prescriptions and markers of nutritional status including records of underweight or codes for growth retardation in children and adolescents, between those with and without mental health conditions. Index date of 01/01/2015 with up to 5 years of follow-up.
Secondary Stream 2 - Secondary outcome - Healthcare utilisation Compare healthcare resource utilisation in children, adolescents and young adults with Inflammatory Bowel Disease with and without mental health conditions. Healthcare resource utilisation will comprise of records of number of primary care contacts and primary care records reporting hospital admission. Hospital admission will be separated into general admission (including for IBD) and psychiatric admission. Index date of 01/01/2015 with up to 5 years of follow-up.
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A